TD-6450
0094
Phase 1 small_molecule completed
Quick answer
TD-6450 for Hepatitis C is a Phase 1 program (small_molecule) at Theravance Biopharma with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Theravance Biopharma
- Indication
- Hepatitis C
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed